Method and system for the administration of a pulmonary surfactant by atomization

US11197965B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11197965-B2
Application numberUS-201415028670-A
CountryUS
Kind codeB2
Filing dateOct 16, 2014
Priority dateOct 22, 2013
Publication dateDec 14, 2021
Grant dateDec 14, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The system allows optimizing the dispensing of aerosol medicaments. In particular the system allows the administration of an exogenous pulmonary surfactant to very young patients (e.g. preterm neonates). A catheter ( 101 ) conveys atomized surfactant directly to the retropharyngeal region in order to increase efficiency of the medicament administration without being invasive: this is particularly important for very young patients, such as pre-term born neonates suffering from neonatal Respiratory Distress Syndrome (nRDS). The catheter is made of biocompatible flexible material (e.g. plastic material). It is possible to couple the catheter with a rigid scaffolding (e.g. metallic) to increase stiffness of the device and to improve easiness of positioning operations. The delivery of the atomized medicament is done by means of an air blasting technique.

First claim

Opening claim text (preview).

The invention claimed is: 1. A system specifically arranged to deliver a medicament comprising a pulmonary surfactant to spontaneously breathing pre-term neonate patients, comprising: a catheter specifically adapted to have a distal end thereof provided in the retro-pharyngeal region of the spontaneously breathing pre-term neonate patient without the presence of an intubation tube and a ventilator, the catheter including at least a first channel adapted to convey in the spontaneously breathing pre-term neonate patient's pharyngeal region a flow of liquid medicament including the pulmonary surfactant in the form of a column, and at least a second channel adapted to convey in the spontaneously breathing pre-term neonate patient's pharyngeal region a pressurized flow of gas, a first pump connected to a first end of the at least first channel, that creates a pressure which pushes the column of liquid medicament towards the second end of the at least first channel; a second pump connected to a first end of the at least second channel, that creates the flow of pressurized gas, wherein the catheter outputs the column of liquid medicament and the pressurized flow of gas according to an air blasting approach such that when the column of liquid medicament and the pressurized flow of gas meet in the pharyngeal cavity, the column of liquid medicament is broken into a plurality of particles to cause an atomized medicament to be delivered into the spontaneously breathing pre-term neonate patient's lungs; and a pressure detecting system, separate from the at least first channel and the at least second channel, adapted to sense pressure swings in the spontaneously breathing pre-term neonate patient's pharyngeal cavity, such sensing being used to determine whether the spontaneously breathing pre-term neonate patient is in an inspiration or in an expiration phase, wherein the first pump is selectively activated only during inspiration phase, the pressure detecting system includes: a third channel adapted to convey a flow of an aqueous solution in the retro-pharyngeal region of the throat of the spontaneously breathing pre-term neonate patient, a third pump connected to a first end of the third channel that creates the flow of the aqueous solution, and a pressure sensor connected to the third channel that measures a value indicative of pressure on the flow of the aqueous solution, the pulmonary surfactant is poractant alfa, the at least second channel includes a plurality of channels arranged around the at least first channel, the at least first channel enlarges towards an end of the at least first channel, and respective cross sections of the plurality of channels decrease towards ends of the channels, the decrease corresponding to the enlargement of the at least first channel. 2. The system according to claim 1 , wherein the third channel is outside of the catheter, axially offset and spaced apart from the at least first channel and the at least second channel. 3. The system according to claim 1 , wherein the catheter is made of flexible plastic material. 4. The system according claim 1 , wherein the at least second channel includes a plurality of channels arranged around the at least first channel, and wherein the third channel is one of the channels arranged around the at least first channel. 5. The system of claim 1 , wherein an external cross section of the third channel is equal to or lower than 2.5 mm. 6. The system according to claim 1 , wherein the pressurized flow of gas includes air. 7. The system according to claim 1 , wherein the aqueous solution includes a physiological saline (0.9% w/v sodium chloride) aqueous solution, buffered at a physiological pH. 8. The system according to claim 1 , wherein the catheter is adapted to provide the plurality of particles for the atomized medicament having droplet median diameter of between 20-100 micron. 9. The system according to claim 1 , wherein an output flow for the first pump is 9-18 ml/hr, and an output flow for the second pump is less than 1 L/min.

Assignees

Inventors

Classifications

  • Multi-lumen tracheal tubes · CPC title

  • Multi-lumen catheters with stationary elements (catheter assemblies comprising a catheter in combination with a guide tube, sheath or sleeve A61M2025/0681; catheters comprising telescoping coaxial elements A61M2025/0175) · CPC title

  • by mixing different fluids, one of them being in a liquid phase · CPC title

  • Respiratory or anaesthetic masks · CPC title

  • A61M11/007Primary

    Syringe-type or piston-type sprayers or atomisers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11197965B2 cover?
The system allows optimizing the dispensing of aerosol medicaments. In particular the system allows the administration of an exogenous pulmonary surfactant to very young patients (e.g. preterm neonates). A catheter ( 101 ) conveys atomized surfactant directly to the retropharyngeal region in order to increase efficiency of the medicament administration without being invasive: this is particular…
Who is the assignee on this patent?
Chiesi Farm Spa
What technology area does this patent fall under?
Primary CPC classification A61M16/0486. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).